{"id":233249,"date":"2018-06-25T23:56:05","date_gmt":"2018-06-25T23:56:05","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=233249"},"modified":"2018-06-25T23:56:05","modified_gmt":"2018-06-25T23:56:05","slug":"creative-biolabs-illustrated-economic-and-efficient-magic-highthroughput-antibody-production-service","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/creative-biolabs-illustrated-economic-and-efficient-magic-highthroughput-antibody-production-service_233249.html","title":{"rendered":"Creative Biolabs Illustrated Economic and Efficient Magic\u2122 High-throughput Antibody Production Service"},"content":{"rendered":"
As an experienced and professional biotech company, Creative Biolabs is always dedicated to the forefront of antibody production and development. Recently, Creative Biolabs announced its high-throughput antibody production for research use officially. The antibody production service harbors the most excellent high-throughput capacity which contributes to the achievement of success.<\/div>\n

June 25, 2018 –<\/strong> Equipped with sophisticated operating platform and advanced bio-technologies, the diligent scientists of R&D in Creative Biolabs are vigilant to any emerging novel concepts and strategies to make the Magic™ High-throughput Antibody Production<\/a> Service perfect. They combined the professional gene synthesis and excellent transient expression technologies to screen and produce a considerable number of target antibodies which are built with superior bioactivities and additional customized advantages.<\/p>\n

“The features of our Magic™ High-throughput Antibody Production Service can easily cover the conventional 96- and 384-well expression, additionally, it can also be expected with superior yield and purity.” introduced Dr. Monika Müller, scientific officer of Creative Biolabs. “and it can be designed to meet different requirements of researchers.”<\/p>\n

“High throughput monoclonal antibody generation<\/a> also has the ability to guarantee a swift screening and producing period in 4 weeks. And then it is possible to offer the desired antibodies in two weeks.” Dr. Monika added.<\/p>\n

The high-throughput antibody production service begins with a specific sequence of a whole antibody or variable region, ends with multiple particular characteristics. With the gorgeous quality control system and well-experienced scientists, it allows Creative Biolabs to offer the target antibodies with 95 % purity. No doubt, the detailed lab report of the whole procedure and optimized parameters is available.<\/p>\n

About Creative Biolabs<\/strong><\/p>\n

With the commitment to pursuing the cutting-edge of antibody production service, Creative Biolabs is trying its best to push the antibody frontline forward with the most competitive price. Additionally, other services, such as recombinant antibody<\/a>, phage display platforms, etc. are also strengths of Creative Biolabs. <\/p>\n

Media Contact<\/span>
Company Name:<\/strong> Creative Biolabs
Contact Person:<\/strong> Bella Smith
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> 1-631-619-7922
Address:<\/strong>45-1 Ramsey Road
City:<\/strong> Shirley
State:<\/strong> New York
Country:<\/strong> United States
Website:<\/strong> https:\/\/www.creativebiolabs.net<\/a><\/p>\n

<\/object><\/p>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

As an experienced and professional biotech company, Creative Biolabs is always dedicated to the forefront of antibody production and development. Recently, Creative Biolabs announced its high-throughput antibody production for research use officially. The antibody production service harbors the most excellent … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401],"tags":[],"class_list":["post-233249","post","type-post","status-publish","format-standard","hentry","category-Business"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/233249","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=233249"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/233249\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=233249"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=233249"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=233249"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}